全球采血针市场

预计到 2030 年全球采血针市场规模将达 66 亿美元

全球采血针市场规模预计在2024年为47亿美元，预计到2030年将达到66亿美元，2024年至2030年的复合年增长率为5.7%。报告分析的细分市场之一「安全」预计复合年增长率为5.6%，到分析期结束时规模将达到28亿美元。标准细分市场在分析期间内的复合年增长率预计为3.8%。

美国市场规模估计为 12 亿美元，中国市场预期复合年增长率为 9.2%

美国采血针市场规模预计2024年达到12亿美元。作为世界第二大经济体，中国市场规模预计到2030年将达到16亿美元，在2024-2030年的分析期间内，复合年增长率为9.2%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为3.0%和4.4%。在欧洲，预计德国市场的复合年增长率为3.8%。

全球采血针市场-主要趋势与驱动因素摘要

采血针如何彻底改变血液采样和患者照护？

采血针是一种用于采集血液样本进行检测的小型医疗设备，在糖尿病等需要定期监测血糖值的疾病管理中至关重要。采血针旨在快速、微创地刺穿皮肤，采集毛细血管血液样本。多年来，安全采血针和一次性器械的研发彻底改变了血液采集方式，并透过降低交叉污染和感染风险提高了病患安全性。采血针广泛应用于临床和居家照护，已成为医疗保健领域不可或缺的工具。

哪些技术创新正在塑造采血针市场？

采血针设计和功能的技术进步提高了采血针的安全性、舒适性和易用性。使用后可缩回的安全采血针在医院和诊断实验室等人流量大的医疗机构中尤其受到重视，因为它们可以防止意外针刺，并降低血液传染的风险。此外，细针技术的进步也使采血针的使用更加舒适，最大限度地减少了采血过程中的疼痛。数位健康和远端监控的日益普及也推动了采血针设计的创新，如今，采血针设备已被整合到血糖监测系统中，并与行动应用程式同步，使患者能够即时追踪数据。

市场区隔将如何定义《采血针》的成长？

采血针的类型包括安全采血针、标准采血针和特殊采血针，其中安全采血针占据最大份额，因为它们广泛用于医院和诊所的感染控制。应用包括血糖值检测、胆固醇检测、血红素检测、过敏检测等，由于全球糖尿病盛行率的上升，血糖值检测占据市场主导地位。最终用户包括医院、诊所、诊断实验室和居家照护机构，随着越来越多的患者选择在家中管理糖尿病等慢性疾病，居家照护正成为关键的成长领域。

哪些因素推动了采血针市场的成长？

采血针市场的成长受到多种因素的推动，例如糖尿病盛行率的上升、家用血糖监测需求的增加以及安全性和舒适性功能的改进。随着全球糖尿病负担的加重，定期血液检测的需求推动了采血针的需求，尤其是在居家照护环境中，患者需要一种方便易用的设备。安全采血针的技术创新降低了感染风险，提高了病患舒适度，进一步推动了市场的成长。此外，在进行胆固醇和血红蛋白等各种检查的诊断实验室中，采血针针的使用日益增多，也扩大了市场。

部分

产品类型（安全、标准、专业）、应用（血糖值测试、血红蛋白测试、胆固醇测试、血液凝固检验、其他应用）、最终用途（医院/诊所、居家医疗、其他最终用途）

受访公司范例

• Arkray
• B. Braun Melsungen
• Becton, Dickinson and Company
• HTL-Strefa SA
• Owen Mumford
• Roche Diagnostics
• Sarstedt
• Sterilance Medical（Suzhou）
• Terumo Corporation
• Ypsomed

人工智慧集成

我们正在利用可操作的专家内容和人工智慧工具来改变市场和竞争情报。

Global Industry Analysts 并未遵循典型的 LLM 或特定产业的 SLM查询，而是建立了一个从全球专家收集的内容库，其中包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 比赛

Global Lancets Market to Reach US$6.6 Billion by 2030

The global market for Lancets estimated at US$4.7 Billion in the year 2024, is expected to reach US$6.6 Billion by 2030, growing at a CAGR of 5.7% over the analysis period 2024-2030. Safety, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$2.8 Billion by the end of the analysis period. Growth in the Standard segment is estimated at 3.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 9.2% CAGR

The Lancets market in the U.S. is estimated at US$1.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 9.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Lancets Market - Key Trends and Drivers Summarized

How Are Lancets Revolutionizing Blood Sampling and Patient Care?

Lancets, small medical devices used to obtain blood samples for testing, are essential in managing conditions such as diabetes, where regular blood glucose monitoring is required. Lancets are designed to make quick and minimally invasive punctures on the skin, allowing for the collection of capillary blood. Over the years, the development of safety lancets and single-use devices has revolutionized blood sampling, improving patient safety by reducing the risk of cross-contamination and infection. Lancets are widely used in both clinical settings and home care, making them an indispensable tool in healthcare.

What Technological Innovations Are Shaping the Lancets Market?

Technological advancements in lancet design and functionality are enhancing their safety, comfort, and ease of use. Safety lancets, which retract after use, prevent accidental needle sticks and reduce the risk of bloodborne infections, making them particularly valuable in high-volume healthcare settings such as hospitals and diagnostic labs. Furthermore, advancements in ultra-thin needle technology have made lancets more comfortable for patients by minimizing pain during blood sampling. The growing popularity of digital health and remote monitoring is also driving innovations in lancet design, with devices now being integrated into blood glucose monitoring systems that sync with mobile apps, allowing patients to track their data in real time.

How Do Market Segments Define the Growth of Lancets?

Types include safety lancets, standard lancets, and specialty lancets, with safety lancets representing the largest segment due to their widespread use in hospitals and clinics for infection control. Applications include blood glucose testing, cholesterol testing, hemoglobin testing, and allergy testing, with blood glucose testing leading the market as the global incidence of diabetes continues to rise. End-users include hospitals, clinics, diagnostic labs, and home care settings, with home care becoming a key growth area as more patients manage chronic conditions like diabetes from the comfort of their homes.

What Factors Are Driving the Growth in the Lancets Market?

The growth in the lancets market is driven by several factors, including the rising prevalence of diabetes, increasing demand for home-based blood glucose monitoring, and advancements in safety and comfort features. As the global burden of diabetes grows, the need for regular blood testing is driving demand for lancets, particularly in home care settings where patients require convenient and easy-to-use devices. Technological innovations in safety lancets, which reduce the risk of infection and improve patient comfort, are further propelling market growth. Additionally, the increasing use of lancets in diagnostic labs for a variety of tests, including cholesterol and hemoglobin testing, is expanding the market.

SCOPE OF STUDY:

The report analyzes the Lancets market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Safety, Standard, Specialty); Application (Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing, Other Applications); End-Use (Hospitals & Clinics, Home Care, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

• Arkray
• B. Braun Melsungen
• Becton, Dickinson and Company
• HTL-Strefa S.A
• Owen Mumford
• Roche Diagnostics
• Sarstedt
• Sterilance Medical (Suzhou)
• Terumo Corporation
• Ypsomed

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Global Economic Update
  • Lancets - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Diabetes and Need for Blood Glucose Monitoring Spurs Growth in Lancets Market
  • Technological Advancements in Safety and Painless Lancets Strengthen Business Case for Adoption
  • Growing Focus on Home Healthcare and Self-Monitoring Expands Addressable Market for Lancets
  • Expansion of Point-of-Care Testing and Diagnostic Devices Fuels Demand for Lancets
  • Rising Demand for Disposable and Single-Use Lancets in Clinical Settings Propels Market Growth
  • Technological Innovations in Needleless and Low-Pain Lancets Propel Market Expansion
  • Increasing Use of Lancets in Blood Sampling for Cholesterol and Hemoglobin Testing Expands Market Opportunities
  • Growing Focus on Patient Comfort and Safety Drives Demand for Advanced Lancet Solutions
  • Rising Adoption of Lancets in Pediatric and Geriatric Care Expands Market Potential
  • Focus on Reducing the Risk of Needlestick Injuries and Contamination Fuels Adoption of Safety Lancets
  • Technological Advancements in Lancets for Continuous Glucose Monitoring Propel Market Growth
  • Rising Use of Lancets in Home Diagnostics and Telehealth Services Expands Market Opportunities
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Blood Glucose Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Blood Glucose Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 3: World 15-Year Perspective for Blood Glucose Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Hemoglobin Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Hemoglobin Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 6: World 15-Year Perspective for Hemoglobin Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Cholesterol Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Cholesterol Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 9: World 15-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Coagulation Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Coagulation Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 12: World 15-Year Perspective for Coagulation Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 15: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 18: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 19: World Recent Past, Current & Future Analysis for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 20: World Historic Review for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 21: World 15-Year Perspective for Home Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 22: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 23: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 24: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 25: World Lancets Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Lancets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Lancets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Lancets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Safety by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Safety by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Safety by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Standard by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Standard by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Standard by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Specialty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Specialty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Specialty by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Lancets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 38: USA Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
• JAPAN
  • Lancets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
• CHINA
  • Lancets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 65: China Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
• EUROPE
  • Lancets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Lancets by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Lancets by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Lancets by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
• FRANCE
  • Lancets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 86: France Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
• GERMANY
  • Lancets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Lancets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 113: UK Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Lancets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Lancets by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Lancets by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Lancets by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Lancets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
• INDIA
  • Lancets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 170: India Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Lancets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Lancets by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Lancets by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Lancets by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Lancets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Lancets by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Lancets by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Lancets by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
• AFRICA
  • Lancets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030

IV. COMPETITION